The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.
An article from
Dive Brief
The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.
Published May 28, 2026
GSK and Ionis' bepirovirsen succeeded in a pair of Phase 3 trials published in the New England Journal of Medicine on May 28, 2026.
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies
Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials
GSK's functional cure data for hepatitis B drug are a major leap over standard of care
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
Epatite B cronica, Gsk: "Con bepirovirsen tassi guarigione funzionale significativi"
Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
Experimental hepatitis B drug may offer 'functional cure' for some patients
Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN
Nova injeção elimina completamente hepatite B em 20% dos pacientes
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for…
GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five…
Findings 'will change the landscape' of treatment, researcher says
GSK has shared detailed results from a pair of late-stage trials testing a chronic hepatitis B treatment originally developed by…
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the…
I risultati dei due studi di Fase III, B-Well 1 e B-Well 2, sono stati pubblicati simultaneamente sul 'New England Journal of…
